Avricore Health Inc.
AVCRF
$0.03
$0.00-3.82%
OTC PK
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -60.64% | -32.98% | -32.98% | 0.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -60.64% | -32.98% | -32.98% | 0.32% |
| Cost of Revenue | -- | -63.94% | -39.90% | -39.90% | -8.02% |
| Gross Profit | -- | -55.26% | -20.74% | -20.74% | 14.47% |
| SG&A Expenses | -- | -1.72% | 18.93% | 18.93% | 1.11% |
| Depreciation & Amortization | -- | 73.68% | 47.37% | 47.37% | 25.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -41.73% | -19.09% | -19.09% | -4.27% |
| Operating Income | -- | -559.87% | -1,157.07% | -1,157.07% | 74.79% |
| Income Before Tax | -- | -1,619.61% | -24,328.57% | -24,328.57% | -156.44% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -1,619.61% | -24,328.57% | -24,328.57% | -156.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -1,619.61% | -24,328.57% | -24,328.57% | -156.44% |
| EBIT | -- | -559.87% | -1,157.07% | -1,157.07% | 74.79% |
| EBITDA | -- | -188.87% | -153.42% | -153.42% | 64.00% |
| EPS Basic | -- | -1,537.50% | -- | -- | -156.00% |
| Normalized Basic EPS | -- | -1,000.00% | -2,600.00% | -2,600.00% | 68.75% |
| EPS Diluted | -- | -3,575.00% | -3,025.00% | -3,025.00% | -203.45% |
| Normalized Diluted EPS | -- | -1,000.00% | -2,600.00% | -2,600.00% | 68.75% |
| Average Basic Shares Outstanding | -- | 1.36% | 1.33% | 1.33% | 1.03% |
| Average Diluted Shares Outstanding | -- | -0.07% | -0.11% | -0.11% | 2.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |